Syncom Formulations Current Share Price | Syncom Formulations Stock Screener
SYNCOMF
Pharmaceuticals
Syncom Formulations Current Stock Price Today
Live Share Price NSE
₹20.04
▲
1.26 (6.71%)
Live Share Price BSE
₹20.02
▲
1.22 (6.49%)
As of September 18, 2026, the live Syncom Formulations share price (NSE: SYNCOMF) is ₹20.04 on NSE and ₹20.02 on BSE, up 6.71% from the previous close, with shares trading between ₹18.80 and ₹20.25 in today's trading session, and a 52-week range of ₹10.30–₹21.39.
Browse Syncom Formulations financial data to support your investment research.
Use the Syncom Formulations stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Syncom Formulations Market Cap
₹1,829.24 Cr.
SYNCOMF P/E Ratio (TTM)
21.24
Syncom Formulations P/B Ratio
4.38
EPS (TTM)
₹0.81
Dividend Yield
-
Debt to Equity
0.12
SYNCOMF 52 Week High
₹21.39
Syncom Formulations 52 Week Low
₹10.30
Operating Margin
16.00%
Profit Margin
16.67%
SYNCOMF Revenue (TTM)
₹150.00
EBITDA
₹37.00
Net Income
₹25.00
Total Assets
₹534.00
Total Equity
₹415.00
Syncom Formulations Current Share Price Chart
Track the current Syncom Formulations share price and stock price with an interactive chart. Analyse SYNCOMF price trends, trading volume, historical performance, and volatility across different timeframes — the complete Syncom Formulations stock quote in one place.
Syncom Formulations Company Profile - Fundamental Screener
Screen Syncom Formulations company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SYNCOMF shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE312C01025
Syncom Formulations Balance Sheet Screener
Screen SYNCOMF balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 534 | 413 | 405 | 378 | 308 | 180 | 175 | 138 |
| Current Assets | 330 | 270 | 275 | 182 | 140 | 83 | 86 | 79 |
| Fixed Assets | 184 | 125 | 120 | 91 | 94 | 55 | 46 | 46 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 15 | 12 | 10 | 9 | 8 | 8 | 6 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 415 | 342 | 288 | 256 | 222 | 117 | 109 | 100 |
| Share Capital | 94 | 94 | 94 | 94 | 86 | 78 | 78 | 78 |
| Reserves & Surplus | 321 | 248 | 194 | 162 | 131 | 39 | 31 | 22 |
Syncom Formulations Income Statement Screener - Profit & Revenue Analysis
Screen Syncom Formulations income statement and profit fundamentals.
Analyze SYNCOMF quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Syncom Formulations share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 150 | 133 | 156 | 123 | 127 | 121 | 78 | 89 | 107 | 132 | 68 | 62 | 68 | 70 | 64 |
| Expenses | 113 | 99 | 131 | 101 | 103 | 94 | 65 | 77 | 90 | 113 | 55 | 53 | 57 | 58 | 56 |
| EBITDA | 37 | 34 | 25 | 22 | 24 | 27 | 13 | 12 | 16 | 19 | 13 | 8 | 10 | 12 | 8 |
| Operating Profit % | 16.00% | 21.00% | 12.00% | 14.00% | 15.00% | 18.00% | 13.00% | 12.00% | 12.00% | 12.00% | 10.00% | 11.00% | 10.00% | 11.00% | 3.00% |
| Depreciation | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 34 | 32 | 23 | 20 | 22 | 25 | 10 | 10 | 15 | 17 | 10 | 6 | 8 | 9 | 6 |
| Tax | 9 | 7 | 6 | 5 | 5 | 6 | 3 | 3 | 4 | 4 | 2 | 2 | 2 | 2 | 1 |
| Net Profit | 25 | 25 | 18 | 16 | 17 | 19 | 7 | 8 | 11 | 13 | 9 | 4 | 7 | 7 | 5 |
| EPS | 0.27 | 0.26 | 0.19 | 0.21 | 0.18 | 0.20 | 0.10 | 0.11 | 0.16 | 0.14 | 0.10 | 0.07 | 0.08 | 0.09 | 0.05 |
Syncom Formulations Cash Flow Screener - Liquidity Fundamentals
Screen SYNCOMF cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 23 | -6 | 11 | 16 | 14 | 24 | 0 |
| Investing Activities | -18 | 83 | -45 | -27 | -18 | -23 | 1 |
| Financing Activities | -68 | -15 | 35 | 8 | 5 | -2 | 1 |
| Net Cash Flow | -63 | 63 | 1 | -3 | 1 | -1 | 2 |
Syncom Formulations Shareholding Pattern Screener
See Syncom Formulations shareholding pattern with promoter, FII, and DII holdings.
Check Syncom Formulations promoter holding and ownership changes for SYNCOMF on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% |
| FII Holding | 0.21% | 0.35% | 0.11% | 0.41% | 0.10% | 0.26% | 0.08% | 0.09% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.15% | 44.90% | 45.20% | 44.83% | 45.21% | 45.04% | 44.85% | 45.08% |
| Other Holding | 4.06% | 4.18% | 4.12% | 4.19% | 4.12% | 4.13% | 4.50% | 4.27% |
| Shareholder Count | 431,690 | 422,114 | 484,529 | 471,066 | 457,364 | 442,280 | 325,761 | 376,530 |
Syncom Formulations Share Dividend Screener - Share Yield Analysis
Check Syncom Formulations dividend history with payout and yield data.
View Syncom Formulations dividend details including ex-dates and amounts for SYNCOMF stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.03 | 0.50% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.02 | 2.06% |
Syncom Formulations Stock Index Membership
See which indices include Syncom Formulations stock.
Check SYNCOMF index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
Syncom Formulations Market Events Screener - Corporate Actions
Get Syncom Formulations corporate actions including splits, bonuses, and buybacks.
Check Syncom Formulations stock events that may affect SYNCOMF share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | 35.49% |
| 2026-09-23 | 2026-09-23 | Dividend | ₹ 0.10 /share | 35.49% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 7.87% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | 4.93% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 6.05% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.56% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | -8.54% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.72% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 6.51% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -1.49% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -5.22% |
| 2023-09-26 | 2023-09-26 | Annual General Meeting | NA | -7.00% |
| 2022-09-09 | 2022-09-13 | Dividend | ₹ 0.03 /share | 0.00% |
Syncom Formulations Competitors Screener - Peer Comparison
Screen SYNCOMF competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Syncom Formulations Company Announcements - News Screener
Screen SYNCOMF latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-12 | Regulation 36(1)(B) Of The SEBI (LODR) Regulations 2015- Dispatch Of Letters To Shareholders Who Have Not Registered Their Email Addresses. | - |
| 2026-09-12 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-12 | Submission Of The Notice Of 38Th Annual General Meeting To Be Held On Wednesday 30Th September 2026. | - |
| 2026-09-12 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015(Listing Regulations): Press Release | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-11 | Corporate Announcement/Information Pursuant To Regulation 44 Of The SEBI (LODR) Regulations 2015 | - |
| 2026-08-11 | Disclosure Pursuant To Regulation 30 Read With Schedule III Of The SEBI (LODR) Regulations 2015. | - |
| 2026-08-11 | Regulation 33(3) Of SEBI (LODR) Regulations 2015- Submission Of The Un-Audited Standalone And Consolidated Financial Results Along With Limited Review Report Thereon For The Quarter Ended 30Th June 2026. | - |
| 2026-08-11 | Corporate Action-Board approves Dividend | - |
| 2026-08-11 | Board Meeting Outcome for Outcome Of The 2/2026-27 Meeting Of The Board Of Directors Of The Company. | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Resignation of Managing Director | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Resignation of Managing Director | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-08-06 | Corporate Action-Board to consider Dividend | - |
| 2026-08-06 | Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Read With SEBI (PIT) Regulations 2015 Regarding Intimation Of Holding The 2/2026-27 Board Meeting Scheduled To Be Held On Tuesday 11Th Day Of August 2026. | - |